Clinical Trial Update: Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing an atorvastatin/fenofibrate combination (LCP-AtorFen) for dyslipidemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• LCP-AtorFen
• atorvastatin/fenofibrate combination (atorvastatin and fenofibrate)

Snippet

Sponsor: Veloxis Pharmaceuticals | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED | Results posted: 2020-02-05